Choices for Potent Platelet Inhibition in Patients With Diabetes Mellitus-Reference-Cited by-同舟云学术

Choices for Potent Platelet Inhibition in Patients With Diabetes Mellitus

Published:2016-09-13 Issue:11 Volume:134 Page:793-796
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Storey Robert F.¹,Parker William A.E.¹

Affiliation:

1. From Cardiovascular Research Unit, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, United Kingdom (R.F.S., W.A.E.P.); and Directorate of Cardiology and Cardiothoracic Surgery, Sheffield Teaching Hospitals NHS Foundation Trust, United Kingdom (R.F.S., W.A.E.P.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.116.023835

Reference16 articles.

1. Antithrombotic Therapy for Secondary Prevention in Patients With Diabetes Mellitus and Coronary Artery Disease

2. Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

3. Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38

4. Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial

5. Development and Clinical use of Prasugrel and Ticagrelor

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aspirin after PCI: in the twilight of its years?;Platelets;2020-07-15

2. Thrombo-Inflammation in Cardiovascular Disease: An Expert Consensus Document from the Third Maastricht Consensus Conference on Thrombosis;Thrombosis and Haemostasis;2020-04

3. Optimal antithrombotic therapy and vascular access site in the management of acute coronary syndromes;European Heart Journal: Acute Cardiovascular Care;2019-09

4. Study of Two Dose Regimens of Ticagrelor Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease;Circulation;2018-09-25

5. Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis;Journal of the American College of Cardiology;2017-10